Agios Pharmaceuticals, Inc. · LSX:A1W2RM

Agios Pharmaceuticals, Inc. insider trades

Agios Pharmaceuticals, Inc.'s insiders made 0 buys and 12 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Gheuens Sarah
Officer: Chief Medical Officer
Sale7,866USD 37.69US$296KOct 26, 2026
Gheuens Sarah
Officer: Chief Medical Officer
Sale500USD 37.52US$18,760Oct 22, 2026
Gheuens Sarah
Officer: Chief Medical Officer
Sale1,489USD 37.53US$55,882Oct 21, 2026
Gheuens Sarah
Officer: Chief Medical Officer
Sale30,000USD 30.48US$914KAug 4, 2026
Gheuens Sarah
Officer: Chief Medical Officer
Sale4,007USD 37.56US$151KJul 1, 2026
Goff Brian
Director, Officer: Chief Executive Officer
Sale12,472USD 34.71US$433KApr 2, 2026
Goff Brian
Director, Officer: Chief Executive Officer
Sale6,596USD 34.71US$229KApr 2, 2026
Viswanadhan Krishnan
Officer: Chief Corp Dev & Strategy
Sale2,959USD 34.71US$103KApr 2, 2026
Milanova Tsveta
Officer: Chief Commercial Officer
Sale3,262USD 34.71US$113KApr 2, 2026
Jones Cecilia
Officer: Chief Financial Officer
Sale3,141USD 34.71US$109KApr 2, 2026
Gheuens Sarah
Officer: Chief Medical Officer
Sale2,940USD 34.71US$102KApr 2, 2026
Burns James William
Officer: Chief Legal Officer
Sale3,280USD 34.71US$114KApr 2, 2026

Agios Pharmaceuticals, Inc. shareholders